Simon D. Roger

8.9k total citations · 1 hit paper
88 papers, 3.7k citations indexed

About

Simon D. Roger is a scholar working on Hematology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Simon D. Roger has authored 88 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 25 papers in Nephrology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Simon D. Roger's work include Erythropoietin and Anemia Treatment (37 papers), Dialysis and Renal Disease Management (21 papers) and Iron Metabolism and Disorders (20 papers). Simon D. Roger is often cited by papers focused on Erythropoietin and Anemia Treatment (37 papers), Dialysis and Renal Disease Management (21 papers) and Iron Metabolism and Disorders (20 papers). Simon D. Roger collaborates with scholars based in Australia, United States and United Kingdom. Simon D. Roger's co-authors include Wajeh Y. Qunibi, David Packham, Philip T. Lavin, Bhupinder Singh, Henrik Rasmussen, Lawrence P. McMahon, Edgar V. Lerma, A. E. G. Raine, Bruce Spinowitz and Adeera Levin and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Simon D. Roger

84 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium Zirconium Cyclosilicate in Hyperkalemia

2014 352 citations David Packham, Philip T. Lavin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon D. Roger Australia	30	1.4k	1.1k	1.1k	635	626	88	3.7k
Bruce Spinowitz United States	24	734 0.5×	983 0.9×	897 0.8×	355 0.6×	411 0.7×	84	2.8k
Philip A. Kalra United Kingdom	44	853 0.6×	2.2k 1.9×	2.0k 1.8×	529 0.8×	1.1k 1.8×	280	6.0k
Daniel W. Coyne United States	39	1.8k 1.3×	670 0.6×	2.4k 2.2×	1.1k 1.7×	484 0.8×	122	5.1k
Lucia Del Vecchio Italy	34	1.2k 0.8×	581 0.5×	2.4k 2.2×	401 0.6×	426 0.7×	175	4.0k
Marc A. Pfeffer United States	19	2.2k 1.6×	739 0.7×	2.9k 2.6×	780 1.2×	2.3k 3.6×	39	6.5k
Yoshiharu Tsubakihara Japan	40	1.3k 0.9×	551 0.5×	3.1k 2.8×	517 0.8×	588 0.9×	143	4.9k
Donal Reddan United States	31	2.3k 1.6×	694 0.6×	2.9k 2.6×	805 1.3×	1.3k 2.0×	72	5.3k
Shelly Sapp United States	32	2.3k 1.6×	468 0.4×	1.4k 1.3×	760 1.2×	3.4k 5.4×	56	7.1k
William E. Smoyer United States	36	294 0.2×	435 0.4×	2.1k 1.9×	399 0.6×	250 0.4×	116	3.5k
Peter Ivanovich United States	23	1.7k 1.2×	309 0.3×	1.5k 1.4×	611 1.0×	323 0.5×	76	3.4k

Countries citing papers authored by Simon D. Roger

Since Specialization

Citations

This map shows the geographic impact of Simon D. Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon D. Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon D. Roger more than expected).

Fields of papers citing papers by Simon D. Roger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon D. Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon D. Roger. The network helps show where Simon D. Roger may publish in the future.

Co-authorship network of co-authors of Simon D. Roger

This figure shows the co-authorship network connecting the top 25 collaborators of Simon D. Roger. A scholar is included among the top collaborators of Simon D. Roger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon D. Roger. Simon D. Roger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rangan, Gopala K., Margaret Allman‐Farinelli, Neil Boudville, et al.. (2024). Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 17(7). sfae159–sfae159. 1 indexed citations

Tang, James, Martin Howell, Vincent Lee, et al.. (2023). Patients’ Perspectives, Factors, and Patterns of eHealth Use in Kidney Transplant Recipients. Kidney International Reports. 8(4). 727–736. 3 indexed citations

Roger, Simon D., David W. Mudge, Craig Nelson, et al.. (2022). The ACTION (AT1R and CCR2 Targets for Inflammatory Nephrosis) Program in Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 33(11S). 798–798.

Pollock, Carol A., et al.. (2020). Roxadustat Increases Hemoglobin in Anemic Non-Dialysis-Dependent (NDD) CKD Patients Independent of Inflammation. Journal of the American Society of Nephrology. 31(10S). 132–133. 1 indexed citations

Charlton, Olivia, et al.. (2019). Nail clubbing in laxative abuse: case report and review of the literature. Journal of Eating Disorders. 7(1). 6–6. 4 indexed citations

McCullough, P. R., Pablo E. Pérgola, Steven Fishbane, et al.. (2017). Abstract 16610: Efficacy and Safety of Sodium Zirconium Cyclosilicate to Treat Hyperkalemia Among Patients Taking Renin-Angiotensin-Aldosterone System Inhibitors in a 12-Month, Open-Label, Phase 3 Study: A Post Hoc Subgroup Analysis. Circulation. 2 indexed citations

Gaillard, Sandrine, Andreas Böck, Fernando Carrera, et al.. (2016). Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. PLoS ONE. 11(6). e0157063–e0157063. 28 indexed citations

Macdougall, Iain C., Simon D. Roger, Angel de Francisco, et al.. (2012). Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney International. 81(8). 727–732. 69 indexed citations

Roger, Simon D., Francesco Locatelli, Rainer P. Woitas, et al.. (2011). C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis. Nephrology Dialysis Transplantation. 26(12). 3980–3986. 39 indexed citations

10.

Roger, Simon D. & Ashraf Mikhail. (2007). Biosimilars: opportunity or cause for concern?. PubMed. 10(3). 405–10. 43 indexed citations

11.

Rossert, Jérôme, Adeera Levin, Simon D. Roger, et al.. (2006). Effect of Early Correction of Anemia on the Progression of CKD. American Journal of Kidney Diseases. 47(5). 738–750. 103 indexed citations

12.

Lindberg, Jill S., Bruce F. Culleton, Gordon Tin Chun Wong, et al.. (2005). Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis. Journal of the American Society of Nephrology. 16(3). 800–807. 312 indexed citations

13.

Coleman, Patrick J., et al.. (2005). Fistula dysfunction secondary to a subcutaneous myelomatous deposit. Nephrology Dialysis Transplantation. 20(12). 2827–2829.

14.

Roger, Simon D., Lawrence P. McMahon, A. R. Clarkson, et al.. (2004). Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4). Journal of the American Society of Nephrology. 15(1). 148–156. 155 indexed citations

15.

Toto, Robert D., Vincent Pichette, Jesús Navarro, et al.. (2004). Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration. American Journal of Nephrology. 24(4). 453–460. 52 indexed citations

16.

McMahon, Lawrence P., Simon D. Roger, & Adeera Levin. (2004). Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease. Journal of the American Society of Nephrology. 15(6). 1640–1647. 60 indexed citations

17.

Rossert, Jérôme, William M. McClellan, Simon D. Roger, & Dierik Verbeelen. (2002). Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?. Nephrology Dialysis Transplantation. 17(3). 359–362. 20 indexed citations

18.

Rossert, Jérôme, William M. McClellan, Simon D. Roger, Dierik Verbeelen, & Walter H. Hörl. (2002). Contribution of anaemia to progression of renal disease: a debate. Nephrology Dialysis Transplantation. 17(suppl_1). 60–66. 29 indexed citations

19.

Raine, A. E. G. & Simon D. Roger. (1991). Effects of erythropoietin on blood pressure.. PubMed. 18(4 Suppl 1). 76–83. 89 indexed citations

20.

Roger, Simon D., Darach Crimmins, Con Yiannikas, & David C.H. Harris. (1990). Lead intoxication in an anuric patient: management by intraperitoneal EDTA. Australian and New Zealand Journal of Medicine. 20(6). 814–817. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact